Left's lawyer, James Spertus, in a court filing argued that the SEC's case 'fails to state a claim because it neither alleges a cognizable theory of fraud...
FILE PHOTO: The seal of the U.S. Securities and Exchange Commission is seen at their headquarters in Washington, D.C.
The securities regulator and the U.S. Justice Department in July accused Left of manipulating the market and defrauding investors with misleading claims about his positions in multiple stocks, including Nvidia and Tesla. Left, who has pleaded not guilty, has for more than a decade been among the most prominent of a cohort of "short activists" who say they bet against public companies on the basis they are over-valued or engaging in outright fraud.More Than 200 Birds and Other Animals Found in N.Y. Home of Veterinarian: 'Literally Unsafe'
U.S. Securities And Exchange Commission James Spertus Misleading Investors SEC
Philippines Latest News, Philippines Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Short Seller Andrew Left Asks Judge to Dismiss SEC Fraud Case(Bloomberg) -- Short seller Andrew Left said a Securities and Exchange Commission lawsuit was accusing him of breaking a rule that doesn’t exist and asked a ...
Read more »
Crypto exchange Coinbase must face shareholder lawsuit over U.S. SEC risksShareholders have accused Coinbase of downplaying the likelihood it would be sued by the U.S. SEC
Read more »
XRP rally ignites despite SEC uncertaintyXRP breaks resistance amid SEC appeal speculation, with reduced exchange outflows driving the price rally despite market caution.
Read more »
CIBC settles with U.S. regulators over record-keeping violationsBank will pay US$30-million to CFTC and US$12-million to SEC; Canaccord Genuity also fined by SEC
Read more »
US SEC charges Mango Markets with offering unregistered crypto tokenThe U.S. Securities and Exchange Commission on Friday charged cryptocurrency trading platform Mango Markets with unregistered sales of its digital asset...
Read more »
Cassava Sciences agrees to $40M SEC fine over Alzehimer's claimsShares of Cassava Sciences (SAVA) are falling after reaching a settlement with US securities regulators. This comes after the pharmaceutical company was...
Read more »